NZ519992A - Pharmaceutical compositions containing electrospun fiber of polymeric carrier integrated with active agent - Google Patents
Pharmaceutical compositions containing electrospun fiber of polymeric carrier integrated with active agentInfo
- Publication number
- NZ519992A NZ519992A NZ519992A NZ51999201A NZ519992A NZ 519992 A NZ519992 A NZ 519992A NZ 519992 A NZ519992 A NZ 519992A NZ 51999201 A NZ51999201 A NZ 51999201A NZ 519992 A NZ519992 A NZ 519992A
- Authority
- NZ
- New Zealand
- Prior art keywords
- agent
- active agent
- poly
- composition according
- process according
- Prior art date
Links
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
- D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/0023—Electro-spinning characterised by the initial state of the material the material being a polymer melt
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Textile Engineering (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Mechanical Engineering (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Manufacturing & Machinery (AREA)
- Dispersion Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17868200P | 2000-01-28 | 2000-01-28 | |
PCT/US2001/002399 WO2001054667A1 (en) | 2000-01-28 | 2001-01-25 | Electrospun pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ519992A true NZ519992A (en) | 2004-04-30 |
Family
ID=22653497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ519992A NZ519992A (en) | 2000-01-28 | 2001-01-25 | Pharmaceutical compositions containing electrospun fiber of polymeric carrier integrated with active agent |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1251829A4 (ja) |
JP (1) | JP2003521493A (ja) |
KR (1) | KR100806412B1 (ja) |
CN (1) | CN1223340C (ja) |
AR (1) | AR028204A1 (ja) |
AU (1) | AU772830B2 (ja) |
BR (1) | BR0107869A (ja) |
CA (1) | CA2396640A1 (ja) |
HU (1) | HUP0301130A3 (ja) |
IL (1) | IL150642A0 (ja) |
MX (1) | MXPA02007298A (ja) |
MY (1) | MY129356A (ja) |
NO (1) | NO20023338L (ja) |
NZ (1) | NZ519992A (ja) |
PL (1) | PL356924A1 (ja) |
TW (1) | TWI289061B (ja) |
WO (1) | WO2001054667A1 (ja) |
ZA (1) | ZA200205989B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9775917B2 (en) | 2013-03-12 | 2017-10-03 | Active Fibres Limited | Nanofibre and bioactive compositions and related methods |
Families Citing this family (118)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9910505D0 (en) | 1999-05-06 | 1999-07-07 | Electrosols Ltd | A method and apparatus for manufacturing consumable tablets |
WO2002032397A2 (en) * | 2000-10-18 | 2002-04-25 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessing in drug delivery and cell encapsulation |
AU2002225700A1 (en) * | 2000-11-17 | 2002-05-27 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessed collagen |
JP2010163435A (ja) * | 2000-11-17 | 2010-07-29 | Virginia Commonwealth Univ Intellectual Property Foundation | 電気処理されたコラーゲン |
EP1377419A4 (en) * | 2001-03-20 | 2004-05-26 | Nicast Ltd | METHOD AND APPARATUS FOR IMPROVING THE MECHANICAL CHARACTERISTICS OF NONWOVEN |
US6685956B2 (en) * | 2001-05-16 | 2004-02-03 | The Research Foundation At State University Of New York | Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications |
GB0123951D0 (en) * | 2001-10-05 | 2001-11-28 | Glaxo Group Ltd | Therapies for treating respiratory diseases |
JP2005523262A (ja) | 2002-02-01 | 2005-08-04 | ファイザー・プロダクツ・インク | 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物 |
KR100549140B1 (ko) | 2002-03-26 | 2006-02-03 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 일렉트로-브로운 방사법에 의한 초극세 나노섬유 웹제조방법 |
ATE533516T1 (de) | 2002-04-04 | 2011-12-15 | Univ Akron Akron Ohio | Nichtgewebte faserverbände |
US8367570B2 (en) | 2002-04-04 | 2013-02-05 | The University Of Akron | Mechanically strong absorbent non-woven fibrous mats |
JP2005522594A (ja) * | 2002-04-11 | 2005-07-28 | セカント メディカル, インコーポレイテッド | 非常に小さいペプチドの電気紡績を使用するカバープロセス |
TW200410714A (en) * | 2002-08-07 | 2004-07-01 | Smithkline Beecham Corp | Electrospun amorphous pharmaceutical compositions |
US20060083784A1 (en) * | 2002-08-07 | 2006-04-20 | Smithkline Beecham Corporation | Amorphous pharmaceutical compositions |
WO2004062697A2 (en) | 2003-01-07 | 2004-07-29 | Tufts University | Silk fibroin materials and use thereof |
BRPI0413277A (pt) | 2003-08-04 | 2006-10-10 | Pfizer Prod Inc | composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas |
BRPI0418330A (pt) | 2003-12-31 | 2007-05-02 | Pfizer Prod Inc | composições sólidas de drogas de solubilidade baixa e poloxámeros |
JP4526851B2 (ja) * | 2004-03-31 | 2010-08-18 | 明彦 谷岡 | 多糖類のナノスケールの繊維および成形体 |
WO2006006746A1 (en) * | 2004-07-09 | 2006-01-19 | Hak-Yong Kim | Polymer particles, and a method for manufacturing the same |
CN100577720C (zh) * | 2005-03-21 | 2010-01-06 | 中国科学院化学研究所 | 可生物降解及吸收的聚合物纳米纤维膜材料及制法和用途 |
JP2006299459A (ja) * | 2005-04-20 | 2006-11-02 | National Institute For Materials Science | 生分解性高分子不織布チューブの製造方法 |
CN1300393C (zh) * | 2005-07-01 | 2007-02-14 | 中国科学院长春应用化学研究所 | 超细纤维药物剂型的乳液电纺丝制备方法 |
DE112006001898B4 (de) * | 2005-07-21 | 2013-05-08 | National Institute For Materials Science | Vorrichtung zur Inhalation von Arzneimitteln |
JP4787585B2 (ja) * | 2005-09-29 | 2011-10-05 | 帝人株式会社 | 静電紡糸法による繊維構造体の製造方法 |
CN100556399C (zh) * | 2005-12-23 | 2009-11-04 | 中国科学院广州化学研究所 | 一种肠靶向型药物控释纤维及其制备方法 |
US8367112B2 (en) | 2006-02-28 | 2013-02-05 | Alkermes Pharma Ireland Limited | Nanoparticulate carverdilol formulations |
KR100824719B1 (ko) * | 2006-09-04 | 2008-04-24 | 주식회사 아모메디 | 전분함유 나노섬유 부직포로 이루어진 생분해성 식품포장재 및 그 제조방법 |
CA2719637C (en) * | 2008-03-27 | 2014-10-28 | Agigma, Inc. | Methods and compositions for the delivery of agents |
MX337657B (es) | 2008-04-16 | 2016-03-14 | Procter & Gamble | Composicion no espumante para el cuidado personal en forma de un articulo. |
EP2328567A2 (de) | 2008-08-08 | 2011-06-08 | Basf Se | Wirkstoffhaltige fasernflächengebilde auf basis von biopolymeren, ihre anwendungen und verfahren zu ihrer herstellung |
EP2323635A2 (de) | 2008-08-08 | 2011-05-25 | Basf Se | Wirkstoffhaltige fasernflächengebilde mit einstellbarer wirkstofffreisetzung, ihre anwendungen und verfahren zu ihrer herstellung |
CN101721751B (zh) * | 2008-10-10 | 2013-01-02 | 张阳德 | 负载了缓释细胞生长因子的具有内核的中空二氧化硅球的人体组织工程支架及其制法和用途 |
US20100291182A1 (en) * | 2009-01-21 | 2010-11-18 | Arsenal Medical, Inc. | Drug-Loaded Fibers |
KR101065255B1 (ko) * | 2009-02-13 | 2011-09-16 | 김근형 | 생분해성 폴리머의 전기방사를 이용한 신규 약물 전달 시스템 |
CN101559242B (zh) * | 2009-05-22 | 2015-07-29 | 广州迈普再生医学科技有限公司 | 一种可同时作为药物缓释体系的纳米人工硬脑膜及其制备方法 |
WO2011029777A1 (de) | 2009-09-11 | 2011-03-17 | Basf Se | Verfahren zur herstellung von beschichteten polymerfasern |
MX339322B (es) | 2009-12-08 | 2016-05-20 | Procter & Gamble | Un sustrato solido, soluble y poroso y recubrimiento fijo de superficie que comprende microesferas de matriz. |
US9173826B2 (en) | 2010-02-16 | 2015-11-03 | The Procter & Gamble Company | Porous, dissolvable solid substrate and surface resident coating comprising a zync pyrithione |
CN101816627B (zh) * | 2010-04-16 | 2012-03-07 | 浙江大学 | 一种协同治疗型多物质缓释滴眼剂及制备方法 |
RU2640933C1 (ru) * | 2010-07-02 | 2018-01-12 | Дзе Проктер Энд Гэмбл Компани | Филаменты, содержащие пригодные для перорального введения активные компоненты, нетканые полотна и способы их изготовления |
EP2588091B1 (en) | 2010-07-02 | 2020-04-15 | The Procter and Gamble Company | Methods of delivering a health care active by administering personal health care articles comprising a filament |
JP5540107B2 (ja) | 2010-07-02 | 2014-07-02 | ザ プロクター アンド ギャンブル カンパニー | 不織布ウェブからフィルムを作製する方法 |
CA2803621C (en) * | 2010-07-02 | 2015-01-06 | The Procter & Gamble Company | Filaments comprising a non-perfume active agent nonwoven webs and methods for making same |
CN105647715B (zh) | 2010-07-02 | 2019-10-25 | 宝洁公司 | 洗涤剂产品 |
US20180163325A1 (en) | 2016-12-09 | 2018-06-14 | Robert Wayne Glenn, Jr. | Dissolvable fibrous web structure article comprising active agents |
CA2803010C (en) * | 2010-07-02 | 2015-11-24 | The Procter & Gamble Company | Dissolvable fibrous web structure article comprising active agents |
BR112013000101A2 (pt) | 2010-07-02 | 2016-05-17 | Procter & Gamble | filamentos compreendendo mantas de não tecido com agente ativo e métodos de fabricação dos mesmos |
BR112013000044B1 (pt) | 2010-07-02 | 2022-01-04 | The Procter & Gamble Company | Método para a distribuição de agentes ativos a artigos de tecido ou superfícies duras |
CN101915797B (zh) * | 2010-07-27 | 2011-09-28 | 北京师范大学 | 一种静电纺丝固定化漆酶电极的制备方法 |
CN103338756B (zh) | 2010-11-26 | 2016-03-02 | 约翰内斯堡金山大学 | 药物剂型 |
WO2012084441A1 (en) | 2010-12-22 | 2012-06-28 | Unilever Nv | Compositions in the form of fibres |
WO2012084427A1 (en) | 2010-12-22 | 2012-06-28 | Unilever Nv | Compositions comprising structured non-aqueous liquid phase |
CZ303244B6 (cs) | 2011-01-17 | 2012-06-13 | Elmarco S.R.O. | Nosic pro oromukosální, zejména pro sublingvální aplikaci fyziologicky aktivních látek |
CN102251317B (zh) * | 2011-05-18 | 2013-01-16 | 东华大学 | 一种药物释放可控的电纺纤维的制备方法 |
WO2013124869A2 (en) * | 2012-02-21 | 2013-08-29 | Amrita Vishwa Vidyapeetham University | The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations |
CN102631715A (zh) * | 2012-05-04 | 2012-08-15 | 江南大学 | 一种抗凝血纳米纤维膜的制备方法 |
CN102670483B (zh) * | 2012-05-09 | 2014-04-02 | 上海交通大学 | 一种用于高血脂症治疗的静电纺丝纤维膜制剂及其制备方法 |
CN102697727B (zh) * | 2012-06-12 | 2014-01-08 | 东华大学 | 一种利用静电纺丝技术制备自组装酮洛芬脂质体的方法 |
KR101454360B1 (ko) | 2012-08-31 | 2014-10-24 | 서울대학교산학협력단 | 파에도닥틸룸 트리코르누툼 추출물을 함유하는 젤라틴 나노섬유 지지체 및 이를 이용한 창상피복재 |
MX370280B (es) | 2012-10-12 | 2019-12-09 | Procter & Gamble | Composición para el cuidado personal en la forma de un artículo disoluble. |
WO2014131376A1 (en) * | 2013-02-26 | 2014-09-04 | Elmarco S.R.O. | Electrospun nanofibers comprising pharmaceutically active agents |
EP2813212A1 (en) | 2013-06-10 | 2014-12-17 | Zentiva, a.s. | Drug formulation using API in nanofibers |
US10202636B2 (en) * | 2013-12-24 | 2019-02-12 | General Electric Company | Electrospun fibers for protein stabilization and storage |
CN106413683A (zh) | 2014-04-22 | 2017-02-15 | 宝洁公司 | 可溶性固体结构体形式的组合物 |
US9877899B2 (en) | 2014-05-05 | 2018-01-30 | The Procter & Gamble Company | Consumer product comprising a fibrous web structure with a silicone conditioning agent coating |
US9861559B2 (en) | 2014-05-05 | 2018-01-09 | The Procter & Gamble Company | Consumer product comprising a porous, dissolvable, fibrous web solid structure with a silicone coating |
US9937111B2 (en) | 2014-05-05 | 2018-04-10 | The Procter & Gamble Company | Consumer product comprising a fibrous web solid structure with a silicone conditioning agent coating |
US9827173B2 (en) | 2014-05-05 | 2017-11-28 | The Procter & Gamble Company | Porous dissolvable solid structure with two benefit agents and methods of forming an aqueous treatment liquor therefrom |
US9861558B2 (en) | 2014-05-05 | 2018-01-09 | The Procter & Gamble Company | Methods of forming an aqueous treatment liquor by dissolving a porous solid with a benefit agent coating |
US9867762B2 (en) | 2014-05-05 | 2018-01-16 | The Procter & Gamble Company | Consumer product comprising a porous dissolvable solid structure and silicone conditioning agent coating |
WO2015189212A1 (en) * | 2014-06-10 | 2015-12-17 | Dermtreat Aps | Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa |
CN105362269A (zh) * | 2014-09-01 | 2016-03-02 | 天津药物研究院 | 一种含蔗糖的罗氟司特片及其制备方法 |
EP3278791A4 (en) * | 2015-03-31 | 2018-10-24 | Orthorebirth Co., Ltd. | Method for manufacturing drug-containing biodegradable fiber material by electrospinning |
CN108025477A (zh) * | 2015-07-07 | 2018-05-11 | 新加坡保健服务集团 | 聚合物产品及其制备 |
CN105327357B (zh) * | 2015-10-14 | 2019-01-11 | 北京科技大学 | 一种邻苯二酚修饰的透明质酸的载药系统及其制备方法 |
RU2701513C2 (ru) * | 2015-11-19 | 2019-09-27 | Афикс Терапьютикс А/С | Фармацевтическая композиция, содержащая электрогидродинамически полученные волокна, композиция, имеющая улучшенное время удержания в месте применения |
JP7126260B2 (ja) * | 2016-01-27 | 2022-08-26 | インスター テクノロジーズ アクチオヴァ スプルチュノスト | 治療処置用の口腔粘膜ナノファイバ担体 |
CN105727358B (zh) * | 2016-02-23 | 2019-01-22 | 广西易得佳医疗器械有限公司 | 载药生物高分子复合纳米纤维膜及其制备方法 |
CN105663025A (zh) * | 2016-02-29 | 2016-06-15 | 浙江工业大学 | 一种含药微丝及其制备方法 |
MX2019008155A (es) | 2017-01-23 | 2019-11-07 | Afyx Therapeutics As | Metodo para preparar fibras electrohiladas con un alto contenido de una sustancia bioadhesiva. |
EP3570821B1 (en) | 2017-01-23 | 2021-07-21 | AFYX Therapeutics A/S | Method for fabrication of a two-layered product based on electrospun fibres |
JP6882519B2 (ja) | 2017-01-27 | 2021-06-02 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | 発泡性凝集粒子を含む溶解性固形構造体形態の組成物 |
MX2019008762A (es) | 2017-01-27 | 2019-09-18 | Procter & Gamble | Composiciones en la forma de estructuras solidas solubles. |
MX2019013048A (es) | 2017-05-16 | 2019-12-11 | Procter & Gamble | Composiciones acondicionadoras para el cuidado del cabello en la forma de estructuras solidas solubles. |
CN107447366A (zh) * | 2017-08-03 | 2017-12-08 | 东华大学 | 一种pH敏感载药缓释纳米纤维膜及其制备方法和应用 |
CA3086689C (en) | 2018-01-26 | 2023-05-09 | The Procter & Gamble Company | Process for making water-soluble articles by cutting a fibrous web in a tessellated pattern |
US20190233785A1 (en) | 2018-01-26 | 2019-08-01 | The Procter & Gamble Company | Water-soluble unit dose articles comprising perfume |
CA3087284C (en) | 2018-01-26 | 2023-05-02 | The Procter & Gamble Company | Water-soluble unit dose articles comprising enzyme |
WO2019147532A1 (en) | 2018-01-26 | 2019-08-01 | The Procter & Gamble Company | Water-soluble unit dose articles comprising perfume |
WO2019168829A1 (en) | 2018-02-27 | 2019-09-06 | The Procter & Gamble Company | A consumer product comprising a flat package containing unit dose articles |
JP7121944B2 (ja) * | 2018-05-07 | 2022-08-19 | 国立大学法人信州大学 | ナノ繊維及びその製造方法 |
JP1629688S (ja) | 2018-07-16 | 2019-04-15 | ||
US10982176B2 (en) | 2018-07-27 | 2021-04-20 | The Procter & Gamble Company | Process of laundering fabrics using a water-soluble unit dose article |
US11666514B2 (en) | 2018-09-21 | 2023-06-06 | The Procter & Gamble Company | Fibrous structures containing polymer matrix particles with perfume ingredients |
WO2020159860A1 (en) | 2019-01-28 | 2020-08-06 | The Procter & Gamble Company | Recycleable, renewable, or biodegradable package |
EP3712237A1 (en) | 2019-03-19 | 2020-09-23 | The Procter & Gamble Company | Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures |
EP3942008A1 (en) | 2019-03-19 | 2022-01-26 | The Procter & Gamble Company | Process of reducing malodors on fabrics |
MX2021013141A (es) | 2019-06-28 | 2021-12-10 | Procter & Gamble | Articulos fibrosos solidos disolubles que contienen surfactantes anionicos. |
CN114025738A (zh) | 2019-07-03 | 2022-02-08 | 宝洁公司 | 包含阳离子表面活性剂和可溶性酸的纤维结构 |
USD939359S1 (en) | 2019-10-01 | 2021-12-28 | The Procter And Gamble Plaza | Packaging for a single dose personal care product |
MX2022002875A (es) | 2019-10-14 | 2022-03-25 | Procter & Gamble | Bolsita biodegradable y/o para compost domestico que contiene un articulo solido. |
MX2022003979A (es) | 2019-11-20 | 2022-04-26 | Procter & Gamble | Estructura solida soluble porosa. |
MX2022005532A (es) | 2019-12-01 | 2022-06-08 | Procter & Gamble | Composiciones acondicionadoras para el cabello con un sistema de conservacion que contiene benzoato de sodio y glicoles y/o esteres de glicerilo. |
IT202000002833A1 (it) * | 2020-02-13 | 2021-08-13 | Bakel S R L | Procedimento di elettrofilatura |
JP2023513376A (ja) * | 2020-02-13 | 2023-03-30 | バケル エス.アール.エル. | 天然ポリマーのエレクトロスピニング法 |
USD962050S1 (en) | 2020-03-20 | 2022-08-30 | The Procter And Gamble Company | Primary package for a solid, single dose beauty care composition |
USD941051S1 (en) | 2020-03-20 | 2022-01-18 | The Procter And Gamble Company | Shower hanger |
USD965440S1 (en) | 2020-06-29 | 2022-10-04 | The Procter And Gamble Company | Package |
EP4188554A1 (en) | 2020-07-31 | 2023-06-07 | The Procter & Gamble Company | Water-soluble fibrous pouch containing prills for hair care |
US11633336B2 (en) | 2020-08-11 | 2023-04-25 | The Procter & Gamble Company | Low viscosity hair conditioner compositions containing brassicyl valinate esylate |
CN116472021A (zh) | 2020-08-11 | 2023-07-21 | 宝洁公司 | 含有芸苔油醇缬氨酸酯乙磺酸盐的清洁冲洗毛发调理剂组合物 |
WO2022036353A1 (en) | 2020-08-11 | 2022-02-17 | The Procter & Gamble Company | Moisturizing hair conditioner compositions containing brassicyl valinate esylate |
JP2023553395A (ja) | 2020-12-01 | 2023-12-21 | ザ プロクター アンド ギャンブル カンパニー | 可溶化抗ふけ活性物質を含有する水性ヘアコンディショナー組成物 |
CN113041230B (zh) * | 2021-03-23 | 2022-06-24 | 浙江尖峰健康科技有限公司 | 一种软胶囊的囊皮及由其制备的软胶囊 |
KR102653460B1 (ko) * | 2021-09-01 | 2024-03-29 | 한남대학교 산학협력단 | 콜라겐과 레시틴을 포함하는 분해도 조절이 가능한 스타치 나노섬유의 제조방법 |
WO2023145886A1 (ja) * | 2022-01-31 | 2023-08-03 | 三菱ケミカル株式会社 | ナノファイバー |
CN114808184A (zh) * | 2022-03-11 | 2022-07-29 | 深圳市法鑫忠信新材料有限公司 | 一种长效驱蚊的静电纺丝纤维及其制备方法和应用 |
CN115887422B (zh) * | 2022-12-31 | 2024-06-07 | 兰州交通大学 | 一种高乌甲素膝骨关节镇痛缓释贴及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1527592A (en) * | 1974-08-05 | 1978-10-04 | Ici Ltd | Wound dressing |
US4855326A (en) * | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
US5567439A (en) | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
US5869098A (en) * | 1997-08-20 | 1999-02-09 | Fuisz Technologies Ltd. | Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
US5980941A (en) * | 1997-08-20 | 1999-11-09 | Fuisz Technologies Ltd. | Self-binding shearform compositions |
US6753454B1 (en) * | 1999-10-08 | 2004-06-22 | The University Of Akron | Electrospun fibers and an apparatus therefor |
-
2001
- 2001-01-25 PL PL01356924A patent/PL356924A1/xx not_active Application Discontinuation
- 2001-01-25 KR KR1020027009477A patent/KR100806412B1/ko not_active IP Right Cessation
- 2001-01-25 CN CNB018042422A patent/CN1223340C/zh not_active Expired - Fee Related
- 2001-01-25 NZ NZ519992A patent/NZ519992A/en not_active IP Right Cessation
- 2001-01-25 MX MXPA02007298A patent/MXPA02007298A/es active IP Right Grant
- 2001-01-25 JP JP2001555646A patent/JP2003521493A/ja active Pending
- 2001-01-25 EP EP01903299A patent/EP1251829A4/en not_active Withdrawn
- 2001-01-25 WO PCT/US2001/002399 patent/WO2001054667A1/en active IP Right Grant
- 2001-01-25 HU HU0301130A patent/HUP0301130A3/hu unknown
- 2001-01-25 IL IL15064201A patent/IL150642A0/xx unknown
- 2001-01-25 CA CA002396640A patent/CA2396640A1/en not_active Abandoned
- 2001-01-25 BR BR0107869-0A patent/BR0107869A/pt not_active Application Discontinuation
- 2001-01-25 AU AU31134/01A patent/AU772830B2/en not_active Ceased
- 2001-01-26 MY MYPI20010355A patent/MY129356A/en unknown
- 2001-01-26 AR ARP010100354A patent/AR028204A1/es unknown
- 2001-02-07 TW TW090101371A patent/TWI289061B/zh not_active IP Right Cessation
-
2002
- 2002-07-11 NO NO20023338A patent/NO20023338L/no not_active Application Discontinuation
- 2002-07-26 ZA ZA200205989A patent/ZA200205989B/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9775917B2 (en) | 2013-03-12 | 2017-10-03 | Active Fibres Limited | Nanofibre and bioactive compositions and related methods |
Also Published As
Publication number | Publication date |
---|---|
BR0107869A (pt) | 2002-11-05 |
AU3113401A (en) | 2001-08-07 |
NO20023338L (no) | 2002-09-03 |
CN1223340C (zh) | 2005-10-19 |
JP2003521493A (ja) | 2003-07-15 |
CA2396640A1 (en) | 2001-08-02 |
PL356924A1 (en) | 2004-07-12 |
EP1251829A1 (en) | 2002-10-30 |
AR028204A1 (es) | 2003-04-30 |
HUP0301130A3 (en) | 2006-07-28 |
MXPA02007298A (es) | 2002-12-09 |
ZA200205989B (en) | 2003-02-03 |
AU772830B2 (en) | 2004-05-06 |
WO2001054667A1 (en) | 2001-08-02 |
HUP0301130A2 (hu) | 2003-09-29 |
CN1396823A (zh) | 2003-02-12 |
EP1251829A4 (en) | 2009-05-06 |
MY129356A (en) | 2007-03-30 |
KR20020082212A (ko) | 2002-10-30 |
NO20023338D0 (no) | 2002-07-11 |
IL150642A0 (en) | 2003-02-12 |
KR100806412B1 (ko) | 2008-02-21 |
TWI289061B (en) | 2007-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU772830B2 (en) | Electrospun pharmaceutical compositions | |
US20030017208A1 (en) | Electrospun pharmaceutical compositions | |
AU2003258120B2 (en) | Electrospun amorphous pharmaceutical compositions | |
AU2004202461B2 (en) | Electrospun pharmaceutical compositions | |
US20060083784A1 (en) | Amorphous pharmaceutical compositions | |
Wang et al. | Electrospun medicated shellac nanofibers for colon-targeted drug delivery | |
Vlachou et al. | Electrospinning and drug delivery | |
Shadambikar et al. | Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology | |
Pisani et al. | Tableted hydrophilic electrospun nanofibers to promote meloxicam dissolution rate | |
CN114748428A (zh) | 一种高载药量的盐酸卡利拉嗪长效缓释微球及其制备方法 | |
CN111450078A (zh) | 一种静电纺丝包载纳米颗粒的药物制剂及其制备和应用 | |
CN114681406B (zh) | 一种卡利拉嗪长效缓释微球及其制备方法 | |
Bitay et al. | One-Step Preparation of Fiber-Based Chlorzoxazone Solid Dispersion by Centrifugal Spinning | |
MODICA DE MOHAC | Novel Drug Delivery System for Treatment-Resistant Schizophrenia | |
Kalayil et al. | Nanofibers for Drug Delivery: Design and Fabrication Strategies | |
Pinarbasli et al. | Prospects of Nanomedicine with Nanocrystal Technology | |
KR20240000406A (ko) | 엔테카비르를 포함하는 장기지속성 미립구 제제 및 이의 제조방법 | |
Barichello et al. | Agatonovic-Kustrin, S., V. Wu, T. Rades, D. Saville, IG Tucker, Powder diffractometric assay of two polymorphic forms of ranitidine hydrochloride 184, 107 Antos-Bielska, M., see Grzybowski, J. 184, 173 Antos-Bielska, M., see Grzybowski, J. 184, 179 | |
Patel et al. | EVALUATION OF CRITICAL MATERIAL ATRRIBUTES (CMA) AND CRITICAL PROCESS PARAMETERS (CPP) FOR FORMULATION OF PLGA BASED MICROSPHERE BY COACERVATION METHOD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
LAPS | Patent lapsed |